Form 8-K - Current report:
SEC Accession No. 0001104659-20-124029
Filing Date
2020-11-12
Accepted
2020-11-12 08:47:51
Documents
4
Period of Report
2020-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2035758d1_8k.htm 8-K 21726
2 EXHIBIT 99.1 tm2035758d1_ex99-1.htm EX-99.1 68602
3 GRAPHIC image_002.jpg GRAPHIC 3439
4 GRAPHIC image_001.jpg GRAPHIC 5911
  Complete submission text file 0001104659-20-124029.txt   104905
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50626 | Film No.: 201303746
SIC: 2834 Pharmaceutical Preparations